Perigon Wealth Management LLC increased its stake in shares of Lam Research Co. (NASDAQ:LRCX – Free Report) by 947.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 40,811 shares of the semiconductor company’s stock after purchasing an additional 36,914 shares during the period. Perigon Wealth Management LLC’s holdings in Lam Research were worth $3,233,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently bought and sold shares of LRCX. Atwood & Palmer Inc. acquired a new position in shares of Lam Research in the fourth quarter worth $27,000. West Oak Capital LLC increased its position in Lam Research by 50.9% during the 4th quarter. West Oak Capital LLC now owns 400 shares of the semiconductor company’s stock worth $29,000 after purchasing an additional 135 shares in the last quarter. Finley Financial LLC acquired a new position in Lam Research in the 4th quarter valued at about $30,000. Householder Group Estate & Retirement Specialist LLC lifted its holdings in Lam Research by 159.1% in the 4th quarter. Householder Group Estate & Retirement Specialist LLC now owns 500 shares of the semiconductor company’s stock valued at $36,000 after purchasing an additional 307 shares in the last quarter. Finally, Laurel Wealth Advisors LLC acquired a new stake in shares of Lam Research during the 4th quarter worth about $37,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities analysts recently issued reports on LRCX shares. The Goldman Sachs Group reduced their price objective on shares of Lam Research from $96.00 to $85.00 and set a “buy” rating on the stock in a research note on Friday, January 10th. Morgan Stanley raised their price objective on Lam Research from $76.00 to $78.00 and gave the stock an “equal weight” rating in a report on Thursday, December 5th. KeyCorp upgraded Lam Research from a “sector weight” rating to an “overweight” rating and set a $95.00 target price for the company in a research note on Friday, January 17th. B. Riley lowered their price target on Lam Research from $132.50 to $105.00 and set a “buy” rating for the company in a report on Wednesday, October 23rd. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $100.00 price objective on shares of Lam Research in a research note on Thursday, October 24th. Nine investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $95.77.
Lam Research Stock Performance
Lam Research stock opened at $74.51 on Wednesday. The firm has a market capitalization of $95.87 billion, a PE ratio of 24.08, a price-to-earnings-growth ratio of 1.53 and a beta of 1.45. Lam Research Co. has a one year low of $68.87 and a one year high of $113.00. The stock’s 50 day moving average price is $75.53 and its 200 day moving average price is $79.37. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.74 and a current ratio of 2.53.
Lam Research Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, January 8th. Stockholders of record on Wednesday, December 11th were paid a $0.23 dividend. The ex-dividend date of this dividend was Wednesday, December 11th. This represents a $0.92 annualized dividend and a dividend yield of 1.23%. Lam Research’s dividend payout ratio (DPR) is presently 29.74%.
Lam Research Profile
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Featured Articles
- Five stocks we like better than Lam Research
- The How and Why of Investing in Gold Stocks
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What is a Low P/E Ratio and What Does it Tell Investors?
- What Does the Future Hold for Eli Lilly?
- How is Compound Interest Calculated?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Co. (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.